SCHEMBL6790747

SCHEMBL6790747

N#CC1(c2ccc(CCC3(C4CCCC4)CC(O)=C(Cc4nc5ncccn5n4)C(=O)O3)cc2F)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3990136 0.98
SCHEMBL6795869 0.90
SCHEMBL6793744 0.89
SCHEMBL3986456 0.88
SCHEMBL3994475 0.87
SCHEMBL3987994 0.87
SCHEMBL6794811 0.87
SCHEMBL3987978 0.86 TSHR (0.34)
SCHEMBL3994093 0.85 KCNQ3 (0.30)
SCHEMBL3992331 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040224960-A1 Pharmaceutical compositions and methods for their use AGOURON PHARMACEUTICALS, INC. 2004-11-11 US claimed
US-7473790-B2 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same PFIZER INC. (US) 2009-01-06 US disclosed
US-20040224960-A1 Pharmaceutical compositions and methods for their use AGOURON PHARMACEUTICALS, INC. 2004-11-11 US disclosed